PARSIPPANY, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, announced it will ring the Nasdaq Closing Bell today in recognition of National Diabetes Awareness Month in November, celebrating the strength, well-being, and individuality of people living with diabetes. Advocacy and professional groups including the Association of Diabetes Care & Education Specialists (ADCES), Beyond Type 1, Beyond Type 2, Camp Nejeda, Children with Diabetes, Diab ...

Key TakeawaysSupermicro shares took a major hit Wednesday after the company didn't say precisely when it would file its 2024 annual report following EY's resignation as auditor.JPMorgan analysts cut their price target by over 50% following the company's business update and earnings call.Super Micro has been given until Nov. 16 to file the report and return to compliance with Nasdaq rules. Super Micro Computer (SMCI) shares fell 20% Wednesday after the company inflamed concerns it could be delisted after it ...

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 500 points on Wednesday.The Dow traded up 3.45% to 43,678.43 while the NASDAQ rose 2.84% to 18,963.41. The S&P 500 also rose, gaining, 2.44% to 5,923.85.Check This Out: How To Earn $500 A Month From Qualcomm Stock Ahead Of Q4 EarningsLeading and Lagging SectorsFinancial shares surged by 5.9% on Tuesday.In trading on Tuesday, real estate shares fell by 3.3%.Top HeadlineJohnson Controls International plc JCI repor ...

PRINCETON, NJ, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company" or "Sonnet”) (NASDAQ: SONN), a clinical-stage company developing innovative targeted immunotherapeutic drugs, today announced the pricing of an underwritten public offering of 1,111,111 shares of common stock (or pre-funded warrants to purchase shares of common stock in lieu of shares of common stock) and common warrants to purchase up to an aggregate of 2,222,222 shares of common stock. Each share of commo ...

Is it a good time to scoop up last month's biggest losers? Check out October's largest price drops on the Nasdaq, and see whether any of them look like good buys today.October 2024 was a fairly quiet month on Wall Street. The major market indices stayed within 3% of their starting scores throughout the month despite economic uncertainty and a nerve-wracking election cycle.But the stock market never sleeps, especially in its more growth-oriented and volatile sectors. Four of the 101 stocks in the NASDAQ-100 ...

NEW YORK and TOKYO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and data consulting services company based in Tokyo, announced today that it has received written notice from the Nasdaq Stock Market LLC that the Company demonstrated compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”) and that the Company is therefore in compliance ...

InMed Pharmaceuticals Announces Decision by NASDAQ Hearings Panel to Grant Exception to Implement Share Consolidation to Satisfy NASDAQ Listing RulesNovember 05, 2024 8:30 AM EST | Source: InMed PharmaceuticalsVancouver, British Columbia--(Newsfile Corp. - November 5, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, toda ...

BOSTON, Nov. 05, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that it has received notice from The Nasdaq Stock Market LLC (Nasdaq) that the Nasdaq Hearings Panel before which TransCode appeared on October 1, 2024, has determined to grant TransCode’s request to continue its listing on The Nasdaq Stock Market subject to certain conditions to regain compliance. The Panel has ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...